stockportfolio.pro
RGC vs TEM: Which Stock Is the Better Buy?
Regencell Bioscience Holdings Limited and Tempus AI, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
AI verdict — RGC vs TEM, read from the filings
The stronger business, the cheaper stock, and the risks — synthesised from both companies’ SEC filings, every figure computed not guessed. Not investment advice.
| Regencell Bioscience Holdings Limited (RGC) | Tempus AI, Inc. (TEM) | |
|---|---|---|
| Market cap | $9.3B | $8.7B |
| Revenue (latest FY) | $0 | $1.27B |
| Net income (latest FY) | $-4.30M | $-245.03M |
| Revenue growth (5y CAGR) | — | 58.3% |
| Net margin | — | -19.3% |
| Return on equity | -52.3% | -49.9% |
| P/E ratio | — | — |
| Dividend yield | — | — |
| Profitable years (of last 10) | 0 | 0 |
| Positive free cash flow | No | No |
See the full RGC vs TEM breakdown
Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.
Open RGC's full financials → Open TEM's full financials →More comparisons
Frequently asked questions
Which is bigger, RGC or TEM?
Regencell Bioscience Holdings Limited is larger by market capitalization — $9.3B versus $8.7B.
Which grows faster, RGC or TEM?
Five-year growth data is not available for both companies.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.
Keep exploring
RGC fundamentals → · TEM fundamentals → · All 1,500+ companies → · Free screener →